• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

1.030 -0.010 (-0.96%)
Streaming Delayed Price Updated: 2:54 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
January 02, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
December 26, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
December 03, 2024
 
Via Benzinga
News headline image
Why Revelation Biosciences (REVB) Stock Is Down 38% ↗
December 03, 2024
Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3. 
Via Benzinga
News headline image
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
December 03, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 02, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
November 11, 2024
 
Via Benzinga
News headline image
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket ↗
November 11, 2024
 
Via Benzinga
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
November 08, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
September 24, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results ↗
August 22, 2024
 
Via Benzinga
News headline image
Gold Down Over 1%; US Initial Jobless Claims Increase ↗
August 22, 2024
 
Via Benzinga
News headline image
Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates ↗
August 22, 2024
 
Via Benzinga
Topics Stocks
News headline image
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
August 22, 2024
 
Via Benzinga
News headline image
Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
August 21, 2024
From Revelation Biosciences Inc.
Via Business Wire
News headline image
US Stocks Higher; Target Posts Upbeat Earnings ↗
August 21, 2024
 
Via Benzinga
News headline image
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗
August 21, 2024
 
Via Benzinga
News headline image
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
August 14, 2024
 
Via Benzinga
News headline image
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024 ↗
August 09, 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
August 09, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday? ↗
June 24, 2024
Revelation Biosciences reveals positive safety and biomarker data from its Phase 1 study (RVL-HV02) of Gemini. The study met its primary endpoint and identified a maximum tolerated dose. 
Via Benzinga
News headline image
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
June 24, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
June 13, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
May 17, 2024
 
Via Benzinga
News headline image
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024 ↗
May 10, 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
May 10, 2024
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
April 22, 2024
 
Via Benzinga
News headline image
REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023 ↗
March 22, 2024
REVB stock results show that Revelation Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
March 22, 2024
From Revelation Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap